BlueCross BlueShield TEC Not Impressed With ECP Therapy Evidence
This article was originally published in The Gray Sheet
Executive Summary
A BlueCross BlueShield Technology Evaluation Center analysis of external counterpulsation therapy builds on a recent CMS proposal intimating that the treatment is not likely to get reimbursement for additional cardiac conditions anytime soon